TOPIC : Development of Quantitative System Toxicology (QST) approaches to improve the understanding of the safety of new medicines
|Publication date:||06 October 2015|
|Types of action:||RIA Research and Innovation action|
|DeadlineModel: Opening date:||two-stage 06 October 2015||Deadline: 2nd stage Deadline:||
12 January 2016 17:00:00
14 June 2016 17:00:00
|Time Zone : (Brussels time)|
Topic DescriptionSpecific Challenge:
Modeling is fundamental to drug development. But there is the need to develop innovative methodologies and practices to integrate the ‘omics analysis and network analysis with quantitative mechanism-based models to form a new approach to drug safety assessment. The emerging field of Quantitative Systems Pharmacology (QSP) seeks to address this methodological gap via the development of mathematical models that account for the mechanisms underlying the response of integrated biological systems at the level of target cells and organs.Scope:
The scope of this proposal is to 1) develop Quantitative Systems Toxicology (QST) models for drug-induced toxicity with the focus on four different organ systems: Heart, Liver, Kidney and the Gastrointestinal (GI)-immune system, and 2) use this QST approach for the prediction of clinical toxicity using preclinical data.Expected Impact:
The results of this action will help to address the needs of the toxicology community for more comprehensive coverage of mechanistic toxicity pathways from which to define a mechanism-based screening approach.
Topic conditions and documents
Please read carefully all provisions below before the preparation of your application.
The budget breakdown for this call is given at the end of the Call topics text, in the Call Conditions section, as well as the following information :
- List of countries and applicable rules for funding
- Eligibility and admissibility conditions
- Evaluation criteria and procedure, scoring and threshold: described in the IMI2 Manual for submission, envaluation and grant award
- Indicative timetable for evaluation and grant agreement
- Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):
Summary of the most relevant provisions for participating in IMI2 actions
Standard proposal template
Standard evaluation form
IMI2 Model Grant Agreement
Template for essential clinial trial information
No submission system is open for this topic.
Contact the IMI Programme Office - E-mail: email@example.com - Tel: +32 2 221 81 81
Contact the SOFIA IT Helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc - E-mail: firstname.lastname@example.org
IMI Partner Search Tool helps you find a partner organisation for your proposal
National Contact Points (NCP) - contact your NCP for further assistance.
Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.
Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.
IT Helpdesk- contact the Participant Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
IMI States Representative Group (SRG) – contact you SRG member for assistance.
IMI JU IT Helpdesk – for IMI2 topics contact the SOFIA IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
Ethics – for compliance with ethical issues, see the Participant Portal and Science and Society Portal
CEN and CENELEC, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at email@example.com.